Fernández-Iglesias Anabel, Gracia-Sancho Jordi
Liver Vascular Biology Research Group, Barcelona Hepatic Hemodynamic Laboratory, IDIBAPS Biomedical Research Institute - CIBEREHD , Barcelona , Spain.
Front Med (Lausanne). 2017 Feb 10;4:7. doi: 10.3389/fmed.2017.00007. eCollection 2017.
Liver microcirculation plays an essential role in the progression and aggravation of chronic liver disease. Hepatic sinusoid environment, mainly composed by hepatocytes, liver sinusoidal endothelial cells, Kupffer cells, and hepatic stellate cells, intimately cooperate to maintain global liver function and specific phenotype of each cell type. However, continuous liver injury significantly deregulates liver cells protective phenotype, leading to parenchymal and non-parenchymal dysfunction. Recent data have enlightened the molecular processes that mediate hepatic microcirculatory injury, and consequently, opened the possibility to develop new therapeutic strategies to ameliorate liver circulation and viability. The present review summarizes the main cellular components of the hepatic sinusoid, to afterward focus on non-parenchymal cells phenotype deregulation due to chronic injury, in the specific clinical context of liver cirrhosis and derived portal hypertension. Finally, we herein detail new therapies developed at the bench-side with high potential to be translated to the bedside.
肝脏微循环在慢性肝病的进展和加重过程中起着至关重要的作用。肝窦环境主要由肝细胞、肝窦内皮细胞、库普弗细胞和肝星状细胞组成,它们密切协作以维持肝脏整体功能以及每种细胞类型的特定表型。然而,持续的肝损伤会显著破坏肝细胞的保护表型,导致实质细胞和非实质细胞功能障碍。近期的数据揭示了介导肝微循环损伤的分子过程,因此,为开发改善肝脏循环和活力的新治疗策略开辟了可能性。本综述总结了肝窦的主要细胞成分,随后聚焦于在肝硬化及相关门静脉高压这一特定临床背景下,由于慢性损伤导致的非实质细胞表型失调。最后,我们在此详细阐述了在实验室研发的、具有很高转化为临床应用潜力的新疗法。